Jan 31, 2024 13:17
TLPH - Talphera, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1.27 0.07 (5.35%) | --- | --- | -0.02 (-1.47%) | 0.0 (0.0%) | 0.05 (3.88%) | --- | 0.0 (0.0%) |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.1
- Diluted EPS:
- Basic P/E:
- -13.4
- Diluted P/E:
- RSI(14) 1m:
- 32.14
- VWAP:
- 1.34
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|